Dose comparison trial of sustained-release fampridine in multiple sclerosis

A. D. Goodman, T. R. Brown, J. A. Cohen, L. B. Krupp, R. Schapiro, S. R. Schwid, R. Cohen, L. N. Marinucci, A. R. Blight

doi:10.1212/01.wnl.0000326213.89576.0e

Dose comparison trial of sustained-release fampridine in multiple sclerosis

DOI Web Site 被引用文献1件

A. D. Goodman

From the Department of Neurology (A.D.G., S.R.S.), University of Rochester, NY; Department of Neurology (T.R.B.), Evergreen Hospital Medical Center, Seattle, WA; Department of Neurology (J.A.C.), Cleveland Clinic Foundation, OH; Department of Neurology (L.K.), Stony Brook University Hospital, NY; Minneapolis Clinic of Neurology (R.S.), MN; and Acorda Therapeutics, Inc. (R.C., L.N.M., A.R.B.), Hawthorne, NY.
T. R. Brown

From the Department of Neurology (A.D.G., S.R.S.), University of Rochester, NY; Department of Neurology (T.R.B.), Evergreen Hospital Medical Center, Seattle, WA; Department of Neurology (J.A.C.), Cleveland Clinic Foundation, OH; Department of Neurology (L.K.), Stony Brook University Hospital, NY; Minneapolis Clinic of Neurology (R.S.), MN; and Acorda Therapeutics, Inc. (R.C., L.N.M., A.R.B.), Hawthorne, NY.
J. A. Cohen

From the Department of Neurology (A.D.G., S.R.S.), University of Rochester, NY; Department of Neurology (T.R.B.), Evergreen Hospital Medical Center, Seattle, WA; Department of Neurology (J.A.C.), Cleveland Clinic Foundation, OH; Department of Neurology (L.K.), Stony Brook University Hospital, NY; Minneapolis Clinic of Neurology (R.S.), MN; and Acorda Therapeutics, Inc. (R.C., L.N.M., A.R.B.), Hawthorne, NY.
L. B. Krupp

From the Department of Neurology (A.D.G., S.R.S.), University of Rochester, NY; Department of Neurology (T.R.B.), Evergreen Hospital Medical Center, Seattle, WA; Department of Neurology (J.A.C.), Cleveland Clinic Foundation, OH; Department of Neurology (L.K.), Stony Brook University Hospital, NY; Minneapolis Clinic of Neurology (R.S.), MN; and Acorda Therapeutics, Inc. (R.C., L.N.M., A.R.B.), Hawthorne, NY.
R. Schapiro

From the Department of Neurology (A.D.G., S.R.S.), University of Rochester, NY; Department of Neurology (T.R.B.), Evergreen Hospital Medical Center, Seattle, WA; Department of Neurology (J.A.C.), Cleveland Clinic Foundation, OH; Department of Neurology (L.K.), Stony Brook University Hospital, NY; Minneapolis Clinic of Neurology (R.S.), MN; and Acorda Therapeutics, Inc. (R.C., L.N.M., A.R.B.), Hawthorne, NY.
S. R. Schwid

From the Department of Neurology (A.D.G., S.R.S.), University of Rochester, NY; Department of Neurology (T.R.B.), Evergreen Hospital Medical Center, Seattle, WA; Department of Neurology (J.A.C.), Cleveland Clinic Foundation, OH; Department of Neurology (L.K.), Stony Brook University Hospital, NY; Minneapolis Clinic of Neurology (R.S.), MN; and Acorda Therapeutics, Inc. (R.C., L.N.M., A.R.B.), Hawthorne, NY.
R. Cohen

From the Department of Neurology (A.D.G., S.R.S.), University of Rochester, NY; Department of Neurology (T.R.B.), Evergreen Hospital Medical Center, Seattle, WA; Department of Neurology (J.A.C.), Cleveland Clinic Foundation, OH; Department of Neurology (L.K.), Stony Brook University Hospital, NY; Minneapolis Clinic of Neurology (R.S.), MN; and Acorda Therapeutics, Inc. (R.C., L.N.M., A.R.B.), Hawthorne, NY.
L. N. Marinucci

From the Department of Neurology (A.D.G., S.R.S.), University of Rochester, NY; Department of Neurology (T.R.B.), Evergreen Hospital Medical Center, Seattle, WA; Department of Neurology (J.A.C.), Cleveland Clinic Foundation, OH; Department of Neurology (L.K.), Stony Brook University Hospital, NY; Minneapolis Clinic of Neurology (R.S.), MN; and Acorda Therapeutics, Inc. (R.C., L.N.M., A.R.B.), Hawthorne, NY.
A. R. Blight

From the Department of Neurology (A.D.G., S.R.S.), University of Rochester, NY; Department of Neurology (T.R.B.), Evergreen Hospital Medical Center, Seattle, WA; Department of Neurology (J.A.C.), Cleveland Clinic Foundation, OH; Department of Neurology (L.K.), Stony Brook University Hospital, NY; Minneapolis Clinic of Neurology (R.S.), MN; and Acorda Therapeutics, Inc. (R.C., L.N.M., A.R.B.), Hawthorne, NY.